Genetic Screening
Add some info about this item
Personalized medicine for psychiatry
The Genecept Assay® is a genetic test used to inform clinicians’ decision-making when prescribing medications and treatments for psychiatric conditions.
Genetic results provide information about the likelihood that a patient will respond to a medication therapy and/or experience adverse events or drug interactions. Treatment decisions informed by these genetic results can offer a personalized treatment plan to objectively address presenting symptoms and side effects. The genes analyzed in the Genecept Assay® are associated with a wide range of psychotropic medications and can help to inform treatment plans for depression, anxiety, obsessive-compulsive disorder (OCD), attention deficit hyperactivity disorder (ADHD), bipolar disorder, post traumatic stress disorder (PTSD), autism, schizophrenia, chronic pain and substance abuse.
This personalized, data-driven approach, which is pain-free and simple to perform, can reduce the time, expense and struggle of finding the right treatment by trial and error.
Transmagnetic Stimulation (TMS)
Add some info about this item
For patients with major depression, antidepressant medication is commonly the first treatment.
In addition, our PAKC physicians are offering another promising non-invasive treatment. In 2008, the FDA approved the use of Transcranial Magnetic Stimulation (TMS) in certain cases where patients have not responded to antidepressant medication.
Research has found that stimulation of neuromuscular tissue can help in treatment of some cases of depression. TMS uses magnetic waves to stimulate or inhibit nerve response, and induce electrical currents in target sections of the cortex, spinal roots and peripheral nerves.
We are one of the first psychiatric practices in the region to offer TMS treatments for depression. This leading-edge approaches require specialized expertise and equipment, which is offered at our dedicated suite at our Leawood location.